SYK Stryker Corp

  1. Stocks
  2. Healthcare
  3. NYSE: SYK

Price (delayed)

$272.58

Market cap

$103.47B

P/E Ratio

39.33

Dividend/share

$2.89

EPS

$6.93

Enterprise value

$114.86B

Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; ...

Highlights
SYK's net income is up by 30% year-on-year and by 11% since the previous quarter
Stryker's EPS has increased by 30% YoY and by 11% from the previous quarter
SYK's P/E is 7% above its last 4 quarters average of 36.9 but 3.8% below its 5-year quarterly average of 40.9
SYK's quick ratio is down by 17% YoY and by 2.3% from the previous quarter
SYK's gross margin is down by 2.5% YoY
Sector: Healthcare
Industry: Medical Devices
Website: https://www.stryker.com/
Peers: MDT BSX EW BAX

Key stats

What are the main financial stats of SYK
Market
Shares outstanding
379.61M
Market cap
$103.47B
Enterprise value
$114.86B
Valuations
Price to earnings (P/E)
39.33
Price to book (P/B)
6.11
Price to sales (P/S)
5.45
EV/EBIT
38.6
EV/EBITDA
34.28
EV/Sales
6.06
Earnings
Revenue
$18.95B
EBIT
$2.98B
EBITDA
$3.35B
Free cash flow
$2.27B
Per share
EPS
$6.93
Free cash flow per share
$5.98
Book value per share
$44.6
Revenue per share
$50.01
TBVPS
$45.39
Balance sheet
Total assets
$36.83B
Total liabilities
$19.94B
Debt
$13.06B
Equity
$16.9B
Working capital
$4.29B
Liquidity
Debt to equity
0.77
Current ratio
1.73
Quick ratio
0.85
Net debt/EBITDA
3.4
Margins
EBITDA margin
17.7%
Gross margin
62.6%
Net margin
13.9%
Operating margin
16.5%
Efficiency
Return on assets
7.2%
Return on equity
16%
Return on invested capital
13.1%
Return on capital employed
9.6%
Return on sales
15.7%
Dividend
Dividend yield
1.06%
DPS
$2.89
Payout ratio
41.7%

SYK stock price

How has the Stryker stock price performed over time
Intraday
0.07%
1 week
-4.48%
1 month
-8.78%
1 year
16.02%
YTD
11.49%
QTD
-4.52%

Financial performance

How have Stryker's revenue and profit performed over time
Revenue
$18.95B
Gross profit
$11.86B
Operating income
$3.13B
Net income
$2.63B
Gross margin
62.6%
Net margin
13.9%
SYK's net income is up by 30% year-on-year and by 11% since the previous quarter
The operating income has grown by 22% year-on-year and by 10% since the previous quarter
SYK's net margin is up by 20% YoY and by 9% from the previous quarter
Stryker's operating margin has increased by 11% YoY and by 7% QoQ

Growth

What is Stryker's growth rate over time

Valuation

What is Stryker stock price valuation
SYK P/E details
P/E
39.33
P/B
6.11
P/S
5.45
EV/EBIT
38.6
EV/EBITDA
34.28
EV/Sales
6.06
Stryker's EPS has increased by 30% YoY and by 11% from the previous quarter
SYK's P/E is 7% above its last 4 quarters average of 36.9 but 3.8% below its 5-year quarterly average of 40.9
SYK's P/B is 13% above its last 4 quarters average of 5.4
SYK's equity is up by 12% year-on-year
The stock's price to sales (P/S) is 14% more than its last 4 quarters average of 4.8 and 2.8% more than its 5-year quarterly average of 5.3
The company's revenue rose by 9% YoY and by 2.7% QoQ

Efficiency

How efficient is Stryker business performance
Stryker's ROIC has increased by 27% YoY and by 12% from the previous quarter
The ROA has grown by 24% YoY and by 11% from the previous quarter
Stryker's ROS has increased by 19% YoY and by 8% from the previous quarter
The ROE rose by 15% YoY and by 8% QoQ

Dividends

What is SYK's dividend history
Dividend details
DPS
$2.89
Dividend yield
1.06%
Payout ratio
41.7%
Recent dividends

Financial health

How did Stryker financials performed over time
The total assets is 85% greater than the total liabilities
SYK's quick ratio is down by 17% YoY and by 2.3% from the previous quarter
The current ratio has declined by 13% year-on-year but it has grown by 6% since the previous quarter
SYK's debt is 23% less than its equity
The debt to equity has contracted by 18% YoY and by 2.5% from the previous quarter
SYK's equity is up by 12% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.